We've updated ourPrivacy Policyto make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read ourCookie Policyhere.

Advertisement
Image of Sarah Whelan

Sarah Whelan

Science Writer

Contact Us

Sarah joined Technology Networks in May 2022 after completing a master’s degree in biochemistry from the University of Kent and a PhD in cancer biology from the University of Leicester, where her research focused on the development of colon cancers. In her role as a science writer and editor, Sarah covers scientific news and a range of other scientific content for the site.


Latest Content
A person taking a blood sample from a patient's arm.
News

Sugar Molecule Levels in Blood Could Predict Alzheimer’s Disease

A new study has found an association between levels of a sugar molecule and a key protein involved in Alzheimer’s disease (AD) in the blood, potentially paving the way for the development of a simple, non-invasive screening test to predict risk of AD.
An image of a robot meeting a human hand.
Industry Insight

Supporting Reproducibility and Accelerating Workflows With Automated Systems

At SLAS 2023, Technology Networks spoke with the PerkinElmer Life Sciences and Diagnostics organization to discuss the launch of two new automated platforms. These innovative systems are designed to improve workflows such as high-throughput drug discovery screening and next-generation sequencing library prep through advances in automation technologies.
A dentist examines the mouth of a patient.
News

Non-Invasive Test Detects Oral Cancers With 92% Accuracy

研究人员已经开发出一种新概念test that can accurately identify people with a common oral cancer as well as pre-cancerous tissue.
Neon lights of a human outline and brain.
News

Clinical Trial of DMT for Depression Announces “Positive” Early Data

Early data from a Phase IIa clinical trial of DMT for major depressive disorder, which has not yet been peer-reviewed, suggests that some patients with MDD may benefit from DMT treatment alongside supportive therapy.
A pregnant woman in a blue shirt holding packets of pills.
News

Most Supplements Do Not Offer Suitable Prenatal Nutrition, Study Suggests

A new study has explored the landscape of supplements used by pregnant women in the United States. The data reveals that 99% of supplements do not provide suitable amounts of some of the key micronutrients missing from women’s diets.
A person filling a green glass with water from a tap.
News

Link Between Lithium Levels in Drinking Water and Autism Risk Identified

A new study in Denmark has reported that pregnant women with high levels of lithium in household tap water may have a higher risk of their children being diagnosed with autism.
This microscope image shows how lung cancer cells invade surrounding tissues and start to spread (metastasize). The depicted lung cancer cells have a mutation of a gene called LKB1 (green) that promotes invasion. Actin, a cytoskeletal protein, is in red, and the cell nucleus is blue.
News

Potential Approach To Combat Cancer Metastasis Identified

A new study has identified the role of a cell signaling pathway in preventing dormant cancer cells from forming aggressive tumors months, or even years, after escaping from their original tumor.
在放大1000倍,这显微照片reveals numbers of rod-shaped, darkly-stained, Clostridium perfringens bacteria.
News

Gut Bacteria Toxin Linked to Onset and Relapse of Multiple Sclerosis

Multiple sclerosis (MS) is a chronic and disabling disease of the central nervous system, and a new study suggests that the onset and relapse of MS may be initiated by a toxin from gut bacteria.
Infographic

Target-Based Drug Discovery

Target-based drug discovery (TBDD) has been the top drug discovery approach for ~30 years. TBDD approaches were developed to improve drug discovery by reducing the costs of bringing a drug to market, increasing throughput and being more straightforward and efficient than other methods.
A packet of contraceptive pills on a blue background.
News

Combined and Progesterone-Only Contraceptives Have a Similar Risk of Breast Cancer

A new study has found that both combined and progesterone-only hormonal contraceptives are associated with a similar relative increase in breast cancer risk of around 20–30%.
Advertisement
Baidu